BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 34 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,076 | -1.1% | 237,000 | 0.0% | 0.02% | -5.3% |
| Q2 2023 | $239,821 | -3.9% | 237,000 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $249,496 | -2.6% | 237,000 | 0.0% | 0.02% | +18.8% |
| Q4 2022 | $256,234 | +7.7% | 237,000 | 0.0% | 0.02% | +23.1% |
| Q3 2022 | $238,000 | +0.4% | 237,000 | 0.0% | 0.01% | -7.1% |
| Q2 2022 | $237,000 | -92.2% | 237,000 | -91.8% | 0.01% | -93.2% |
| Q4 2021 | $3,022,000 | -83.4% | 2,879,000 | -84.0% | 0.21% | -85.2% |
| Q3 2021 | $18,211,000 | +21.8% | 18,021,000 | +21.6% | 1.39% | +2.3% |
| Q2 2021 | $14,947,000 | – | 14,821,000 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,002 | $52,121,000 | 3.69% |
| MACKAY SHIELDS LLC | 77,043,000 | $76,896,000 | 1.94% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,534,000 | $33,470,000 | 0.61% |
| LOOMIS SAYLES & CO L P | 2,190,467 | $185,686,000 | 0.38% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,139,000 | 0.09% |
| Jefferies Group LLC | 8,306,000 | $8,275,194 | 0.07% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $15,840,000 | 0.04% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,700,000 | $13,605,000 | 0.03% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 14,000 | $14,000 | 0.02% |
| AVIVA PLC | 3,000,000 | $3,005,000 | 0.02% |